U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07653971) titled 'ZVS101e in Patients With Bietti's Crystalline Dystrophy' on June 12.
Brief Summary: The goal of this clinical trial is to evaluate the safety and early effectiveness of ZVS101e in patients with Bietti crystalline dystrophy who meet the eligibility criteria for treatment under the translational application program in the Hainan Boao Lecheng International Medical Tourism Pilot Zone.
Participants will:
undergo screening and baseline assessments to confirm eligibility; receive a single subretinal injection of ZVS101e in the study eye; complete follow-up visits over 4 weeks after treatment for safety monitoring and assessment of early ...